Dr.
Kizzmekia “Kizzy” Corbett (1986- ), viral immunologist. Kizzmekia
Shanta Corbett was born and raised in the small North Carolina town of Hurdle
Mills, part of a large extended family, and grew up in nearby Hillsborough. She
showed high intelligence at a young age, and her mother later remembered her as
being “like a little detective, my sweet little, opinionated detective.” Her
third-grade teacher encouraged her mother and stepfather to demand that the
school district put her in on the most demanding academic track, something they
rarely did for black children. While in high school she interned in a research
laboratory at the University of North Carolina, where she studied the bacteria
that causes scarlet fever and worked with a grad student who later became a
department chair at Tuskegee University; “I didn’t even know that this thing
called a Ph.D. even really existed,” she later said, “Or, at least I didn’t
know what it meant. And so, to have someone going through the graduate school
process who was a familiar face – he was a black man from Alabama – really kind
of helped me.” She received a full scholarship to the University of Maryland,
Baltimore County, part of a fellowship program that has produced more African
Americans in the medical field than any other predominantly white institution. While
in college Corbett studied the pathogenesis (origin and development) of pseudotuberculosis
(a bacteria that causes scarlet fever-like conditions), worked as a lab
technician and as a biological sciences trainer at the National Institutes of
Health (NIH), did field work on health outcomes in underserved minority
communities, and graduated with a degree in biological sciences and sociology.
While interning at the NIH she met the head of the Vaccine Research Center, who
asked what she wanted to do with her life, and she answered, “I want your job.”
She then earned a Ph.D. in microbiology and immunology from the University of
North Carolina in 2014. Her dissertation research included working in Sri Lanka
to study how the body produces antibodies to fight dengue fever, a tropical
disease spread by mosquitos, and the role that genetics play in this process.
After completing her Ph.D., Corbett became a viral
immunologist at the NIH with a focus on viral pathogenesis and host immunity.
She gave particular attention to the Severe Acute Respiratory Syndrome (SARS)
and Middle East Respiratory Syndrome (MERS), which collectively infected more
than 10,000 people around the world in the early 21st century. These
viruses caused Corbett to begin exploring such diseases due to concern that
another one could spread in the future; in her words, “these big, challenging
questions remained, along with the fact that it was clear that it could happen
again. It was looming out there and just a matter of time.” SARS and MERS are
both part of a virus group called coronaviruses, which cause respiratory tract
infections and are named for the fact that they physically resemble a solar
corona. Some coronaviruses produce conditions such as the common cold and
pneumonia, but a new one called SARS-Co-V-2 causes coronavirus disease 2019,
also known as COVID-19. This disease is carried in fluids such as saliva and
mucus and is spread in two ways: first, by inhaling the droplets that people
release when exhaling, talking, sneezing, or coughing; or second, by touching a
surface that has been contaminated with those droplets within the last 72 hours
and then touching their own eyes, nose, or mouth. Its transmission can be prevented
by vigorous and frequent hand washing, maintaining social distance from people
outside of one’s household, wearing face masks in public, and keeping one’s unwashed
hands away from the face. COVID-19 first spread from bats to humans in China in
December 2019 and rapidly spread around the world. As of April 2020 there have
been more than 2.4 million confirmed cases, 624,000 recoveries, and 165,000
deaths in 185 different countries. The U.S. currently leads all countries in
those categories due in part to a slow response and conflicting messages from
the federal government, and more than 41,000 Americans have died. In an effort
to stop its spread until a vaccine is developed, much of the global economy and
human society in general has partly or completely shut down, with schools and
universities switching to online learning, sporting events cancelled or
postponed, limited human interaction, heightening of problems such as anxiety
and domestic abuse, people in white-collar jobs working remotely from home, and
numerous businesses closing and employees losing their jobs. The U.S. currently
has the highest unemployment rate since the Great Depression in the early
1930s. The disease has also severely affected African Americans due to
preexisting social inequalities. Black Americans disproportionately suffer from
higher rates of conditions such as heart disease, diabetes, and asthma, have
less access to health care, live in crowded urban neighborhoods where social
distancing is less possible; and work in professions where contact with
infected persons is more likely. As a result, for instance, African Americans are
22% of North Carolina’s population but 38% of COVID-19 deaths, while in Chicago
they comprise 30% of the population but 68% of deaths.
©David Brodnax, Sr.
No comments:
Post a Comment